Cambridge Anti-Myopia Trial: Accommodation Training and Aberration Control in Myopia Development
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J O'Leary, PhD
University of Wales Institute Cardiff
Study Director - Ebi P Osuobeni, PhD
Anglia Ruskin University
Principal Investigator - Hema Radhakrishnan, PhD
University of Manchester
Principal Investigator - Peter M Allen, PhD
Anglia Ruskin University
Study Chair - Richard I Calver, PhD
Anglia Ruskin University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anglia Ruskin University
Cambridge, Cambridgeshire, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2005
- Primary completion
- —
- Completion
- —
- Last update posted
- 17 Oct 2006
- Registered enrollment
- 200
- Registry id
- NCT00317551
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.